Ranked #961 of 8,699 institutional investors
Siren, L.L.C.
New York, NY
$3.91B
US stock portfolio at live prices · today −$14.1M (−0.36%)
Live prices, last trade 9:44 AM ET
- Value at quarter end (Q3 2026)
- $4.22B
- Change from Q2 2026
- −$706.4M (−14.34%)
- Positions
- 96 · 11 new, 18 sold out
- Filed
- Nov 12, 2026
Not counted in the ranking: call options on $12.3M of stock. $153M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSRRK 12.2%KYMR 8.45%ERAS 4.73%ONC 4.69%MANE 4.13%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SRRK Scholar Rock Holding Corporation | 9,375,013 | $475M | 12.2% | Reduced −2% |
| KYMR Kymera Therapeutics, Inc. | 2,784,898 | $330M | 8.45% | Reduced −5% |
| ERAS Erasca, Inc. | 13,197,781 | $185M | 4.73% | Added +16% |
| ONC BeOne Medicines AG | 465,000 | $183M | 4.69% | Unchanged |
| MANE Veradermics Inc | 1,324,299 | $161M | 4.13% | Reduced −20% |
| TNGX Tango Therapeutics, Inc. | 6,784,081 | $152M | 3.88% | Added +10% |
| RVMD Revolution Medicines, Inc. | 850,000 | $141M | 3.60% | Reduced −6% |
| RYTM Rhythm Pharmaceuticals, Inc. | 1,086,275 | $127M | 3.24% | Reduced −4% |
| EWTX Edgewise Therapeutics, Inc. | 2,804,179 | $114M | 2.93% | Reduced −12% |
| ARWR Arrowhead Pharmaceuticals, Inc. | 2,290,476 | $100M | 2.57% | Added +34% |
| COAG Hemab Therapeutics Holdings, Inc. | 2,366,235 | $94.6M | 2.42% | Added +13% |
| SYRE Spyre Therapeutics, Inc. | 868,598 | $84.7M | 2.17% | Reduced −10% |
| PBLS Parabilis Medicines, Inc. | 2,992,259 | $81.5M | 2.09% | Unchanged |
| LXRX Lexicon Pharmaceuticals, Inc. | 44,303,518 | $74.0M | 1.89% | Unchanged |
| ELVN Enliven Therapeutics, Inc. | 1,475,163 | $68.3M | 1.75% | Reduced −17% |
| IRON Disc Medicine, Inc. | 888,401 | $67.7M | 1.73% | Unchanged |
| TYRA Tyra Biosciences, Inc. | 3,395,887 | $67.4M | 1.72% | Added +368% |
| SEPN Septerna, Inc. | 1,700,000 | $65.8M | 1.68% | Reduced −11% |
| AMLX Amylyx Pharmaceuticals, Inc. | 2,480,586 | $64.0M | 1.64% | Added +68% |
| SLN Silence Therapeutics plc | 2,887,867 | $57.2M | 1.46% | Reduced −13% |
| STOK Stoke Therapeutics, Inc. | 1,995,347 | $54.1M | 1.38% | Unchanged |
| RLAY Relay Therapeutics, Inc. | 3,262,976 | $51.7M | 1.32% | Reduced −11% |
| SLDB Solid Biosciences Inc. | 7,690,405 | $49.3M | 1.26% | Unchanged |
| BCAX Bicara Therapeutics Inc. | 5,502,970 | $49.2M | 1.26% | Reduced −2% |
| COGT Cogent Biosciences, Inc. | 1,609,279 | $44.1M | 1.13% | Reduced −13% |
| DYN Dyne Therapeutics, Inc. | 2,429,125 | $39.5M | 1.01% | Added +14% |
| RCUS Arcus Biosciences, Inc. | 2,420,430 | $38.7M | 0.99% | Unchanged |
| CYTK Cytokinetics, Incorporated | 708,952 | $37.2M | 0.95% | Reduced −7% |
| TSHA Taysha Gene Therapies, Inc. | 9,846,579 | $36.6M | 0.94% | Unchanged |
| OLMA Olema Oncology, Inc. | 4,856,949 | $34.3M | 0.88% | Unchanged |
| RELY Remitly Global, Inc. | 1,543,271 | $31.5M | 0.81% | Unchanged |
| PVLA Palvella Therapeutics, Inc. | 207,485 | $30.2M | 0.77% | Reduced −19% |
| ADRX ADARx Pharmaceuticals, Inc. | 1,925,794 | $27.2M | 0.70% | New |
| XENE Xenon Pharmaceuticals Inc. | 718,306 | $26.8M | 0.69% | Reduced −46% |
| ORIC ORIC Pharmaceuticals, Inc. | 3,358,192 | $25.9M | 0.66% | Added +12% |
| DNLI Denali Therapeutics Inc. | 1,396,513 | $25.6M | 0.65% | Unchanged |
| KLRA Kailera Therapeutics, Inc. | 2,214,286 | $25.5M | 0.65% | Unchanged |
| GOOGL Alphabet Inc. | 80,000 | $22.3M | 0.57% | Reduced −11% |
| DBVT DBV Technologies S.A. | 2,356,539 | $22.0M | 0.56% | Added +27% |
| TRVI Trevi Therapeutics, Inc. | 1,523,889 | $20.9M | 0.54% | Reduced −15% |
| SPTX Seaport Therapeutics, Inc. | 1,095,316 | $19.4M | 0.50% | Unchanged |
| MNPR Monopar Therapeutics Inc. | 270,118 | $18.6M | 0.48% | Unchanged |
| MSFT Microsoft Corporation | 34,000 | $16.9M | 0.43% | Reduced −9% |
| CGEM Cullinan Therapeutics, Inc. | 1,793,410 | $16.4M | 0.42% | Reduced −5% |
| RAPP Rapport Therapeutics, Inc. | 641,469 | $15.2M | 0.39% | Unchanged |
| TSM Taiwan Semiconductor Manufacturing Company Limited | 45,000 | $15.2M | 0.39% | Added +1% |
| ABVX ABIVAX Société Anonyme | 188,000 | $14.9M | 0.38% | Reduced −67% |
| GPCR Structure Therapeutics Inc. | 872,967 | $14.7M | 0.38% | Unchanged |
| AGEN Agenus Inc. | 2,419,263 | $14.5M | 0.37% | Added +127% |
| ANNX Annexon, Inc. | 4,359,560 | $14.4M | 0.37% | Reduced −2% |
| RZLT Rezolute, Inc. | 3,328,287 | $13.6M | 0.35% | Unchanged |
| NVDA NVIDIA Corporation | 97,500 | $13.6M | 0.35% | Added +3% |
| ENGN enGene Therapeutics Inc. | 6,256,662 | $11.2M | 0.29% | Unchanged |
| ABSI Absci Corporation | 1,374,764 | $10.9M | 0.28% | Reduced −44% |
| AVGO Broadcom Inc. | 29,500 | $9.9M | 0.25% | Added +18% |
| YARW Yarrow Bioscience, Inc. | 675,000 | $9.5M | 0.24% | New |
| SKHY SK hynix Inc. | 80,000 | $9.1M | 0.23% | New |
| DT Dynatrace, Inc. | 190,000 | $8.5M | 0.22% | Added +23% |
| NOW ServiceNow, Inc. | 90,000 | $8.0M | 0.21% | Reduced −10% |
| IKT Inhibikase Therapeutics, Inc. | 5,850,000 | $7.8M | 0.20% | Unchanged |
| GENB Generate Biomedicines, Inc. | 736,104 | $7.6M | 0.19% | Unchanged |
| WHWK Whitehawk Therapeutics, Inc. | 2,337,102 | $7.2M | 0.19% | Unchanged |
| CTMX CytomX Therapeutics, Inc. | 3,457,711 | $7.1M | 0.18% | Unchanged |
| ACRS Aclaris Therapeutics, Inc. | 2,025,000 | $7.1M | 0.18% | New |
| AMZN Amazon.com, Inc. | 21,500 | $5.5M | 0.14% | Reduced −34% |
| MSLE Satellos Bioscience Inc. | 892,074 | $5.2M | 0.13% | Unchanged |
| DSGN Design Therapeutics, Inc. | 523,212 | $4.9M | 0.13% | Unchanged |
| CRWD CrowdStrike Holdings, Inc. | 20,000 | $4.6M | 0.12% | Reduced −50% |
| JMKE Jersey Mike's Subs Inc. | 250,000 | $4.5M | 0.11% | New |
| ELOX Eloxx Pharmaceuticals, Inc. | 400,000 | $4.3M | 0.11% | Unchanged |
| KRRO Korro Bio, Inc. | 347,718 | $4.2M | 0.11% | Unchanged |
| IONQ IonQ, Inc. | 170,000 | $3.7M | <0.1% | Unchanged |
| ODTX Odyssey Therapeutics, Inc. | 200,000 | $3.5M | <0.1% | Unchanged |
| NMRA Neumora Therapeutics, Inc. | 8,497,822 | $3.0M | <0.1% | Unchanged |
| DDOG Datadog, Inc. | 18,000 | $2.9M | <0.1% | Reduced −55% |
| OUST Ouster, Inc. | 100,000 | $2.7M | <0.1% | Added +48% |
| VTVT vTv Therapeutics Inc. | 163,000 | $2.7M | <0.1% | Unchanged |
| IVVD Invivyd, Inc. | 5,000,000 | $2.3M | <0.1% | Unchanged |
| AGMB AgomAb Therapeutics NV | 411,250 | $2.2M | <0.1% | Unchanged |
| GTLB GitLab Inc. | 50,000 | $2.2M | <0.1% | Reduced −60% |
| BAC Bank of America Corporation | 40,000 | $1.9M | <0.1% | New |
| TTMI TTM Technologies, Inc. | 30,000 | $1.8M | <0.1% | New |
| PALI Palisade Bio, Inc. | 2,000,000 | $1.8M | <0.1% | Unchanged |
| AEVA Aeva Technologies, Inc. | 200,000 | $1.8M | <0.1% | Added +37% |
| MGM MGM Resorts International | 43,000 | $1.4M | <0.1% | New |
| SCHW The Charles Schwab Corporation | 15,000 | $1.4M | <0.1% | New |
| FANG Diamondback Energy, Inc. | 7,500 | $1.3M | <0.1% | New |
| FHTX Foghorn Therapeutics Inc. | 720,720 | $1.3M | <0.1% | Unchanged |
| ZTS Zoetis Inc. | 12,500 | $1.0M | <0.1% | Reduced −64% |
| RANI Rani Therapeutics Holdings, Inc. | 1,594,800 | $907K | <0.1% | Reduced −20% |
| ADAG Adagene Inc. | 421,658 | $835K | <0.1% | Reduced −84% |
| FIG Figma, Inc. | 50,000 | $832K | <0.1% | Unchanged |
| GOSS Gossamer Bio, Inc. | 65,112 | $723K | <0.1% | Unchanged |
| PRMB Primo Brands Corporation | 25,000 | $588K | <0.1% | New |
| QNT Quantinuum Inc. | 20,000 | $564K | <0.1% | Unchanged |
| KLRS Kalaris Therapeutics, Inc. | 356,559 | $471K | <0.1% | Reduced −18% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| DFTX Definium Therapeutics, Inc. | 1,419,493 | $40.6M |
| COF Capital One Financial Corporation | 171,615 | $31.4M |
| ORKA Oruka Therapeutics, Inc. | 250,000 | $24.0M |
| PDD PDD Holdings Inc. | 95,000 | $8.1M |
| BABA Alibaba Group Holding Limited | 50,000 | $4.2M |
| SEER Seer, Inc. | 2,458,673 | $3.5M |
| WK Workiva Inc. | 45,000 | $2.9M |
| MPLT MapLight Therapeutics, Inc. | 450,000 | $2.8M |
| SION Sionna Therapeutics, Inc. | 610,515 | $1.8M |
| BEKE KE Holdings Inc. | 100,000 | $1.8M |
| NBP NovaBridge Biosciences | 2,004,739 | $1.7M |
| NFLX Netflix, Inc. | 25,000 | $1.5M |
| TSLA Tesla, Inc. | 3,500 | $1.3M |
| MDLN Medline Inc. | 25,000 | $951K |
| FOXA Fox Corporation | 10,000 | $652K |
| TENX Tenax Therapeutics, Inc. | 427,141 | $568K |
| T AT&T Inc. | 25,000 | $558K |
| LITE Lumentum Holdings Inc. | 1,055 | $521K |